CFTR and cystic fibrosis: Although this classification can be useful as guidance for defining the disease liability and treatment for the patient, CF patients can harbor modifiers genes or different CFTR genotypes, that cause combinatorial defects in the CFTR channel, which may contribute to the variable clinical response to available CF drugs [8,9].